23andMe Inks $3.5B Deal With Richard Branson-Backed SPAC
Genetic testing company 23andMe, guided by Morgan Lewis, will trade publicly after merging with a Davis Polk-advised special purpose acquisition company backed by Richard Branson's Virgin Group, in a deal announced...To view the full article, register now.
Already a subscriber? Click here to view full article